| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 24, 2003
Accepted on April 15, 2003
1 Department of Medicine and Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215; Department of Neurology, Beth Israel Deaconess Medical Center, and Program in Neuroscience, Harvard Medical School, Boston, MA, 02215
* To whom correspondence should be addressed. E-mail: jelmquis{at}bidmc.harvard.edu,.
Over the past decade, there has been a tremendous increase in the understanding of the molecular and neural mechanisms that control food intake and body weight. Yet, eating disorders and cachexia are still common and obesity cases are rising at alarming rates. Thus, despite recent progress, an increased understanding of the molecular and neural substrates that control body weight homeostasis is a major public health goal. In this review, we discuss the mechanisms by which metabolic signals interact with key behavioral, neuroendocrine and autonomic regulatory regions of the central nervous system (CNS). Additionally, we offer a model in which hormones such as leptin and ghrelin interact with similar CNS circuits and engage them in such a way as to maintain an appropriate and tight regulation of body weight and food intake. Our model predicts that over- or under-stimulation of these central pathways can result in the obesity, anorexia or cachexia.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |